HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Success of the two-dose methotrexate protocol for treatment of ectopic pregnancy in women with a history of prior ectopic pregnancy.

AbstractOBJECTIVE:
Women with prior ectopic pregnancy (EP) have an increased failure rate when treated with single-dose methotrexate (MTX) for subsequent EP. We sought to determine whether previous EP remained a risk factor for failure when using the two-dose MTX protocol.
STUDY DESIGN:
Retrospective cohort study of women managed with two-dose MTX. Risk factors for MTX failure were evaluated in univariable analysis and multivariable regression modeling.
RESULTS:
A total of 234 women with EP between 1999 and 2009 were studied. Of those, 37 (15.8%) had a prior EP. In univariable analysis, prior EP was associated with a greater than twofold increased risk of MTX failure (RR 2.67, 95% CI 1.20-3.77). Higher hCG levels and ultrasound visualization of EP also increased the risk of MTX failure. In multivariable analysis hCG level remained associated with MTX failure, while prior EP did not (adjusted RR 0.97, 95% CI 0.33-2.82).
CONCLUSION:
Prior EP is not independently associated with MTX failure in women receiving two-dose MTX therapy after controlling for known risk factors.
AuthorsJanet F McLaren, Kurt T Barnhart, Mary D Sammel, Dina H Appleby, Samantha F Butts
JournalThe Journal of reproductive medicine (J Reprod Med) 2014 Jul-Aug Vol. 59 Issue 7-8 Pg. 379-84 ISSN: 0024-7758 [Print] United States
PMID25098028 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Abortifacient Agents, Nonsteroidal
  • Chorionic Gonadotropin
  • Methotrexate
Topics
  • Abortifacient Agents, Nonsteroidal (administration & dosage)
  • Adult
  • Chorionic Gonadotropin (analysis)
  • Cohort Studies
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Methotrexate (administration & dosage)
  • Multivariate Analysis
  • Pregnancy
  • Pregnancy, Ectopic (diagnostic imaging, drug therapy)
  • Recurrence
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Treatment Failure
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: